Skip to main content
. 2022 Nov 9;12:1000807. doi: 10.3389/fonc.2022.1000807

Figure 2.

Figure 2

Potential therapeutic targets for GC liver metastasis. The inhibition of the CXCR4/CXCR7-CXCL12 axis in the liver, suppression of M1-type KCs to M2-type KCs conversion, and blockade the binding of receptors secreted by liver resident cells binding to receptors on GC cells might destroy the TME of liver metastasis.